Total Funding
26
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 26 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
101743
Respicardia develops implantable therapies to improve respiratory and cardiovascular health.
Acquired by 

ZOLL Medical Corporation
- Robin Germany: Chief Medical OfficerPast Role: University of Oklahoma, Clinical Assistant Professor
- Tim Hauch: Chief Financial OfficerPast Role: SuperDimension, Vice President of Business Development
About the Company
Respicardia (formerly Cardiac Concepts) is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē® System, is an implantable stimulation device that is designed to restore a more normal breathing pattern
during sleep for patients with central sleep apnea. Respicardia® is committed to improving cardiovascular health…one breath at a time™.


